🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/12/2005 64,49 65,70 63,60 64,20 -0,05% 3,26% 502.900
21/12/2005 62,38 65,15 62,11 64,23 +2,98% 4,87% 844.400
20/12/2005 61,42 63,25 61,25 62,37 +1,43% 3,26% 378.400
19/12/2005 62,30 62,49 60,96 61,49 -1,30% 2,46% 485.700
16/12/2005 61,95 63,42 61,25 62,30 +0,81% 3,50% 645.800
15/12/2005 61,23 62,20 61,23 61,80 +0,90% 1,58% 362.800
14/12/2005 62,55 62,66 61,19 61,25 -2,16% 2,35% 430.900
13/12/2005 61,85 63,17 61,42 62,60 +1,11% 2,83% 353.900
12/12/2005 62,17 62,25 61,10 61,91 -0,16% 1,85% 457.400
09/12/2005 62,64 62,64 61,57 62,01 -0,93% 1,71% 298.000
08/12/2005 61,44 63,29 61,22 62,59 +1,74% 3,37% 677.600
07/12/2005 61,14 61,52 59,90 61,52 +1,30% 2,65% 1.120.900
06/12/2005 62,00 62,00 60,46 60,73 -1,99% 2,48% 427.500
05/12/2005 60,97 62,04 59,68 61,96 +1,92% 3,87% 510.100
02/12/2005 59,75 61,10 59,75 60,79 +2,24% 2,26% 752.200
01/12/2005 59,50 59,80 59,21 59,46 -0,42% 0,99% 482.600
30/11/2005 59,77 60,37 59,29 59,71 -0,05% 1,81% 533.600
29/11/2005 60,52 60,52 59,40 59,74 -0,58% 1,85% 517.100
28/11/2005 61,34 61,68 60,00 60,09 -2,97% 2,74% 533.700
25/11/2005 62,19 62,45 61,70 61,93 -0,15% 1,21% 139.500
23/11/2005 61,87 62,87 61,50 62,02 +0,08% 2,21% 410.000
22/11/2005 60,85 62,85 60,58 61,97 +1,62% 3,73% 641.600
21/11/2005 59,68 60,98 59,10 60,98 +2,20% 3,15% 491.400
18/11/2005 58,00 60,14 57,87 59,67 +3,99% 3,91% 915.000
17/11/2005 56,20 57,57 55,92 57,38 +2,81% 2,94% 532.100
16/11/2005 55,90 56,19 55,29 55,81 +0,16% 1,61% 391.500
15/11/2005 56,02 56,30 55,00 55,72 -0,75% 2,32% 360.600
14/11/2005 56,33 56,62 55,73 56,14 +0,16% 1,58% 293.500
11/11/2005 54,79 56,48 54,79 56,05 +1,71% 3,08% 457.000
10/11/2005 54,72 55,42 53,19 55,11 +0,36% 4,08% 433.200